LONDON (ChurchMilitant.com) - A damning investigation by a London-based foundation that specializes in exposing the "human impact of corporate greed," is revealing the criminal histories of the seven vaccine oligarchs manufacturing and pushing the so-called vaccine for the China virus.
The report, titled "The horrible history of Big Pharma: Why we can't leave pharmaceutical corporations in the driving seat of the COVID-19 response," is warning that the pharmaceutical industry model is "a serious obstacle" to ending the coronavirus crisis.
The 46-page investigation by Global Justice Now exposes fraud, bribery, price gouging, violation of medical ethics, tax dodging, lobbying, preventing competition by unfair means, and profiteering from public funding while offering little to the public in return.
Global Justice Now — a pro-vaccine organization — is urging governments to impose strict conditions on jab giants, including full disclosure of all deals with pharma companies and an end to "cutthroat competition and secrecy."
The "controversies and malpractices" surrounding the pharma behemoths "show we cannot trust them to provide safe and fair solutions to the global pandemic," authors Dr. James Angel and Nick Dearden emphasize in the December report.
Pfizer, a key Vatican ally, was forced to pay $2.3 billion for illegally marketing the arthritis drug Bextra and other unapproved drugs, as well as for paying kickbacks to doctors. This was the largest health care fraud settlement and the biggest criminal fine in history as of 2009, the report notes.
A whistleblower claimed sales reps were incentivized to sell Bextra to doctors for conditions for which the drug wasn't approved and at doses up to eight times those recommended.
Pfizer's price gouging over its anti-epilepsy drug phenytoin resulted in Britain's National Health Service expenditure on phenytoin capsules rising from about £2 million a year in 2012 to about £50 million in 2013. Pfizer raised the price of 100 mg packs of the drug from £2.83 to £67.50, before reducing it to £54 from May 2014 — a price hike of 2,300% to 2,600%.
The United Kingdom's Competition and Markets Authority fined Pfizer £84.2 million — the highest penalty it had ever levied on a drug company. The fine was overturned on appeal, and the CMA is exploring the next steps against Pfizer.
Pfizer also paid compensation of $75 million to the state of Kano in Nigeria as well as $175,000 each to four families after 11 children died and several children were left with brain damage, paralysis or slurred speech in clinical trials for its meningitis drug.
Pfizer fought a 15-year-legal battle against the Nigerians, who alleged the company did not have consent from parents to use an experimental drug on their children — a case that inspired John le Carré's novel and movie The Constant Gardener.
WikiLeaks' release of U.S. state department cables suggest the drug manufacturer may have blackmailed the head of Nigeria's Ministry of Justice into dropping a $6 billion criminal lawsuit.
The Global Justice Now investigation also blasts British-Swedish biotech company AstraZeneca (AZ) for fraud, product hopping and transfer pricing.
AZ paid a $520 million settlement in 2010 for fraud after it was found to have illegally marketed its antipsychotic drug Seroquel for uses not approved as safe and effective by the U.S. Food and Drug Administration.
The company was also forced to pay almost $350 million to resolve thousands of lawsuits alleging links between Seroquel and diabetes, the report noted.
According to Global Justice Now, AZ has "a track record of product hopping (making minor changes in a drug as its patent is about to expire and rebranding to block new competitors) particularly with regards to indigestion and stomach ulcer medication."
The European Court of Justice fined AZ 60 million euros in 2005 for abusing its market position to delay the introduction of generic versions of its stomach ulcer treatment Losec.
In 2010, AZ paid £505 million to British Revenue and Customs after a 15-year dispute relating to "transfer pricing," whereby profits from a subsidiary in a higher tax jurisdiction are registered to another subsidiary in a lower tax jurisdiction.
"Safety concerns are especially significant in the context of COVID-19 vaccine development," the Global Justice Now report emphasized.
AZ has received a $1 billion investment from the U.S. government. The U.K. government also invested £67.7 million in the AZ Oxford University research and trials.
Over 20 countries paused the AZ jab in March 2021 following a spike in young people suffering severe clotting disorders and strokes after receiving the jab.
Beating Pfizer's 2009 fine for the biggest penalty in pharma history, GlaxoSmithKline's $3 billion fine was levied in 2012 after the company admitted to bribing American doctors and encouraging the prescription of the unsuitable antidepressant Paxil to children.
GSK also incentivized sales reps to missell three drugs to doctors — meaning the products were misrepresented or the customer was misled about suitability — and flew pliant doctors and their spouses to five-star resorts in Bermuda, Jamaica and California. The pharma giant also paid for articles on its drugs to appear in medical journals.
In 2013, GSK allegedly bribed doctors, hospitals and others at least three billion yuan (HK$3.8 billion) to boost sales in China. China fined the British company $500 million for bribery in 2014.
Meanwhile, Johnson & Johnson, the world's largest drug company, was ordered to pay damages of $4.7 billion in 2018 to sufferers of ovarian cancer who alleged their illness was caused by J&J talc-based baby powder.
By 2019, J&J agreed to a $120 million settlement and paid out about $1 billion in lawsuits over its subsidiary DePuy Orthopedics' misrepresentation of the effectiveness, durability and safety of hip replacement products, which were found to violate consumer protection laws. In 2010, J&J was forced to recall seven over-the-counter children's medicines.
Following allegations of botched Ebola vaccine trials in Ghana and J&J's failure to listen to concerns of Democratic Republic of the Congo officials, DRC health minister Dr. Oly Ilunga Kalenga refused to let clinical trials of J&J's Ebola jab go ahead.
The pharma giant has come under fire for refusing to grant scientists access to three HIV drugs for which it holds key patents — rilpivirine, darunavir and etravirine — preventing these from being duplicated for poorer countries.
Moderna has no products currently on the market apart from its vaccine — paid for entirely by the taxpayer with $2.5 billion of public money.
Nevertheless, Moderna's jab is one of the most expensive on the market, with costs estimated at $64 and $74 per person per course under a special cheaper "pandemic pricing" regime, Global Justice Now reports.
An anti-corruption watchdog group is urging the U.S. Securities and Exchange Commission to investigate top executives at Moderna after executives at Moderna reportedly sold more than $180 million of stock in automated sales for the year.
Moderna Therapeutics, valued at over $5 billion, is estimated to be the United States' most valuable private biotech company, with several top executives raking in billions in sales of Moderna shares.
Moderna Therapeutics received an initial $20 million grant from the Bill & Melinda Gates Foundation in 2016, before the COVID crisis — with a total commitment of $100 million in funding toward mRNA-based treatments.
Moderna CEO Stéphane Bancel sold nearly $2 million of his stock ahead of Moderna's emergency-use vaccine filing, according to filings registered with the Securities and Exchange Commission and is now worth $3 billion.
The vaccine oligarch's "stock sale was carried out through a routine Rule 10b5-1, a predetermined trading plan that allows company executives to sell shares at set times without facing insider trading accusations," a Business Insider investigation revealed.
In March 2020, Moderna cofounder Noubar Afeyan, whom Forbes estimates to have a net worth of $2.3 billion, sold more than $1.5 billion in shares, cashing in on the pandemic.
Moderna has also been slammed for failing to reveal the data behind its COVID-19 trial results — a strategy it used for the first two so-called vaccines it brought to trial. The company even refused to disclose which diseases the products targeted and did not list the trials publicly.
Meanwhile, French vaccine-maker Sanofi is facing possible manslaughter charges for allegedly failing to warn pregnant women about the risk of birth defects from the epilepsy drug Depakine. A 2017 study by France's National Agency for the Safety of Medicines and Health Products estimated that between 2,150 and 4,100 children suffered severe malformations linked to the drug.
The Philippines permanently withdrew the license for Sanofi's dengue fever vaccine Dengvaxia in 2017 after widespread safety concerns and allegations around the deaths of several children.
Prosecutors launched criminal cases against pediatrician and researcher Dr. Rose Capeding and 19 others, including Sanofi officials, for "reckless imprudence resulting [in] homicide," because they "facilitated with undue haste" Dengvaxia's approval and rollout among Philippine schoolchildren.
Despite major controversies over Gilead's COVID-19 treatment remdesivir, the pharma giant is estimated to rake in $7.7 billion for sales of the drug by 2022.
"Remdesivir has no clinical efficacy against COVID, according to every legitimate study," writes Robert F. Kennedy, Jr. in The Real Anthony Fauci: Bill Gates, Big Pharma, and the Global War on Democracy and Public Health. "Worse, it is deadly poisonous, and expensive poison at $3,000 for treatment."
"Remdesivir, it turned out, was hideously dangerous. Within 28 days, subjects taking remdesivir had lethal side effects including multiple organ failure, acute kidney failure, septic shock and hypotension, and 54% of the remdesivir group died," Kennedy writes.
In 2019, after hundreds of millions of dollars in taxpayer money went into research that led to the patents for the HIV drug Truvada, the Trump administration announced it would sue Gilead for infringing upon patents.
Gilead has also become notorious for price gouging and has been accused of dodging tens of billions of dollars in tax via Irish tax loopholes.
The Bill & Melinda Gates Foundation owns a $6.5 million stake in Gilead.
"There are several indications that suggest a vaccine lobby that dominates in the Vatican and pushes the pope and secretary of state to take decisions that go against even recent magisterial documents," Riccardo Cascioli, editor of Italy's New Daily Compass wrote in a column Thursday.
In light of recent revelations of Pope Francis' secret meetings with Pfizer CEO Albert Bourla, Church Militant asked Vatican whistleblower Abp. Carlo Maria Viganò why the pontiff and the Vatican were "allying themselves with criminals" when Big Pharma's criminal history is widely known and is in the public domain.
"The corruption of the pharmaceutical industry, although well known, is deliberately ignored because Big Pharma is one of the main allies of the globalist oligarchy in the pursuit of The Great Reset," Viganò told Church Militant.
The outspoken prelate and former Vatican nuncio to the United States elaborated:
The Bergoglian church is also an ally of the New World Order, and the crimes committed under the pretext of the pandemic are culpably silenced by Bergoglio because he hopes to gain political advantage. This coup will be thwarted, and with it the sect of heretics and corrupt forces that occupy the Vatican will inexorably collapse.
"For more than 25 years, Johnson & Johnson has been a leader in supporting the LGBTQ+ community through its employee policies, business practices and public advocacy," as "the company aims to be a strong ally during Pride Month — and beyond," the J&J website states.
The Vatican also accepted funding from Moderna for its controversial May 2021 global health conference on "Exploring the Mind, Body and Soul," inviting Moderna's and Pfizer's CEOs as featured speakers to its global health gig, Church Militant reported.
Gilead, J&J and Sanofi are stakeholders in the Vatican's Rome Action Plan. Gilead also partnered with the Vatican and dioceses in northern Tanzania to reach people with HIV.
Dr. Alan Moy, founder of the John Paul II Medical Research Institute, said it was "disturbing that Pope Francis and the Vatican are blindly pushing from large pharmaceutical companies vaccines that are not only morally tainted but are ineffective and unsafe."
The scientist explained to Church Militant the implications of the Vatican's alliance with Big Pharma:
Smaller organizations like the John Paul II Medical Research Institute, which is trying to develop an ethical and more robust and durable vaccine, as well as drugs for other conditions that are free of aborted fetal cells, has never received any support from the Vatican when approached. The possible explanation is that small organizations like JP2MRI lack the war chest of Big Pharma to lobby and influence the Vatican. The time has arrived for the development of a pro-life biotechnology industry sector that not only respects Catholic values but is more focused on genuine scientific innovation that advances public health.
Catholics were outraged after Italian television revealed the Vatican held shares worth 20 million euros in two Swiss pharmaceutical companies: Roche and Novartis. Novartis makes and sells the abortifacient through its subsidiary Sandoz.
Church Militant contacted the Holy See Press Office, the Cura Foundation and Aleteia's www.catholic-factchecking.com asking why no questions of the criminal histories of the drug oligarchs were raised in the hierarchy's push for the COVID jabs, but received no response.